Myeloproliferative Neoplasms and Sodium-Glucose Co-Transporter-2 Inhibitors: A Case Series

Turk J Haematol. 2024 May 30;41(2):130-132. doi: 10.4274/tjh.galenos.2024.2024.0050. Epub 2024 Apr 1.

Authors

Püsem Patır¹, Kübra Çerçi², Erdal Kurtoğlu¹

Affiliations

¹ University of Health Sciences Türkiye, Antalya Training and Research Hospital, Clinic of Hematology, Antalya, Türkiye
² University of Health Sciences Türkiye, Antalya Training and Research Hospital, Department of Internal Medicine, Antalya, Türkiye

No abstract available

Keywords: Myeloproliferative neoplasms; Gliflozins; Thrombosis.

Publication types

Letter
Case Reports

MeSH terms

Aged
Female
Humans
Male
Middle Aged
Myeloproliferative Disorders* / drug therapy
Sodium-Glucose Transporter 2 Inhibitors* / adverse effects
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Sodium-Glucose Transporter 2 Inhibitors